These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Advances in the treatment of metastatic colorectal cancer. Fishman AD; Wadler S Clin Colorectal Cancer; 2001 May; 1(1):20-35. PubMed ID: 12445376 [TBL] [Abstract][Full Text] [Related]
24. 25th European Society for Medical Oncology Congress. Hamburg, Germany. October 13-17, 2000. D'Orazio AI; Gambill BD Clin Colorectal Cancer; 2001 May; 1(1):10-5. PubMed ID: 12445373 [No Abstract] [Full Text] [Related]
25. Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer. Cartwright T; Kuefler P; Cohn A; Hyman W; Berger M; Richards D; Vukelja S; Nugent JE; Ruxer RL; Boehm KA; Asmar L Clin Colorectal Cancer; 2008 Nov; 7(6):390-7. PubMed ID: 19036692 [TBL] [Abstract][Full Text] [Related]
26. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages. Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311 [TBL] [Abstract][Full Text] [Related]
27. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients]. Kato K Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003 [No Abstract] [Full Text] [Related]
28. Optimizing the use of irinotecan in colorectal cancer. Cunningham D; Maroun J; Vanhoefer U; Van Cutsem E Oncologist; 2001; 6 Suppl 4():17-23. PubMed ID: 11585970 [TBL] [Abstract][Full Text] [Related]
29. [The development of the first line treatment of metastatic colorectal cancer (mCRC)]. Landherr L; Nagykálnai T Magy Onkol; 2009 Sep; 53(3):237-46. PubMed ID: 19793687 [TBL] [Abstract][Full Text] [Related]
30. Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters. Ku GY; Haaland BA; de Lima Lopes G Cancer Chemother Pharmacol; 2012 Aug; 70(2):231-8. PubMed ID: 22699811 [TBL] [Abstract][Full Text] [Related]
31. Common side effects and interactions of colorectal cancer therapeutic agents. Holt K J Pract Nurs; 2011; 61(1):7-20. PubMed ID: 21751717 [No Abstract] [Full Text] [Related]
32. New drugs in the treatment of colorectal carcinoma. Punt CJ Cancer; 1998 Aug; 83(4):679-89. PubMed ID: 9708931 [TBL] [Abstract][Full Text] [Related]
33. Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study. Chu E Clin Colorectal Cancer; 2008 Jul; 7(4):226. PubMed ID: 18650190 [No Abstract] [Full Text] [Related]
34. Chemotherapy for colorectal cancer. Goyle S; Maraveyas A Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107 [TBL] [Abstract][Full Text] [Related]
35. New options for outpatient chemotherapy--the role of oral fluoropyrimidines. Cunningham D; Coleman R Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541 [TBL] [Abstract][Full Text] [Related]
36. What's new in ... colorectal cancer. Meaningful progress in therapy options. Polansky M; Ross AC JAAPA; 2009 Apr; 22(4):51-2. PubMed ID: 19452823 [No Abstract] [Full Text] [Related]